Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis - Concepedia

Concepedia

Publication | Open Access

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

DOI Full Paper Access

69

Citations

33

References

2023

Year

Tingli Guo, Wenhui Yan, Xin Cui, Na Liu, Xiaotong Wei, Yuzhuo Sun, Kexin Fan, Jieyun Liu, Yuan‐Yuan Zhu, Zhuanzhuan Wang,

Molecular Medicine

References

	Year	Citations

Page 1